Challenges and Management of Acute Coronary Syndrome in Cancer Patients

Imagem de Miniatura
Arquivos
art_COSTA_Challenges_and_Management_of_Acute_Coronary_Syndrome_in_2021.PDF (3.41 MB)
Citações na Scopus
16
Tipo de produção
article
Data de publicação
2021
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
FRONTIERS MEDIA SA
Autores
COSTA, Maycon Santos
Citação
FRONTIERS IN CARDIOVASCULAR MEDICINE, v.8, article ID 590016, 9p, 2021
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Cancer and cardiovascular disease are the leading causes of mortality in the world. The prevalence of cardiovascular risk factors and coronary artery disease in cancer patients is elevated, and it is associated with high mortality. Several mechanisms, such as the proinflammatory and procoagulant states present in cancer patients, may contribute to these scenarios. Oncological therapy can predispose patients to acute thrombosis, accelerated atherosclerosis and coronary spasm. Treatment decisions must be individualized and based on the cancer history and balancing bleeding and thrombosis risks.
Palavras-chave
acute coronary syndrome, cancer, cardiotoxicity, coronary disease, cardio oncology
URI
https://observatorio.fm.usp.br/handle/OPI/41328
Referências
  1. Bharadwaj A, 2020, EUR HEART J, V41, P2183, DOI 10.1093/eurheartj/ehz851
  2. Bradshaw PT, 2016, EPIDEMIOLOGY, V27, P6, DOI 10.1097/EDE.0000000000000394
  3. Breccia M, 2015, AM J HEMATOL, V90, pE100, DOI 10.1002/ajh.23976
  4. Brenner B, 2018, AM J MED, V131, P1095, DOI 10.1016/j.amjmed.2018.04.037
  5. Canale ML, 2019, ANTICANCER RES, V39, P4619, DOI 10.21873/anticanres.13642
  6. Capodanno D, 2018, J AM COLL CARDIOL, V72, P2915, DOI 10.1016/j.jacc.2018.09.057
  7. Chen XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066721
  8. Choueiri TK, 2010, J CLIN ONCOL, V28, P2280, DOI 10.1200/JCO.2009.27.2757
  9. Collet JP, 2021, EUR HEART J, V42, P1289, DOI 10.1093/eurheartj/ehaa575
  10. Cortes JE, 2013, NEW ENGL J MED, V369, P1783, DOI 10.1056/NEJMoa1306494
  11. Costa F, 2019, J AM COLL CARDIOL, V73, P741, DOI 10.1016/j.jacc.2018.11.048
  12. Falanga Anna, 2019, Cancer Treat Res, V179, P11, DOI 10.1007/978-3-030-20315-3_2
  13. Feher A, 2017, ONCOLOGIST, V22, P213, DOI 10.1634/theoncologist.2016-0110
  14. Flack KF, 2017, CLIN GASTROENTEROL H, V15, P682, DOI 10.1016/j.cgh.2016.10.011
  15. Ganatra S, 2017, JACC-CARDIOVASC INTE, V10, P2334, DOI 10.1016/j.jcin.2017.06.068
  16. Genereux P, 2015, EUROINTERVENTION, V11, P634, DOI 10.4244/EIJY14M10_05
  17. Gietema JA, 2000, LANCET, V355, P1075, DOI 10.1016/S0140-6736(00)02044-4
  18. Guha A, 2020, MAYO CLIN PROC, V95, P1865, DOI 10.1016/j.mayocp.2020.05.044
  19. Haugnes HS, 2010, J CLIN ONCOL, V28, P4649, DOI 10.1200/JCO.2010.29.9362
  20. Herrmann J, 2016, CIRCULATION, V133, P1272, DOI 10.1161/CIRCULATIONAHA.115.018347
  21. Ibanez B, 2018, EUR HEART J, V39, P119, DOI 10.1093/eurheartj/ehx393
  22. Iliescu CA, 2016, CATHETER CARDIO INTE, V87, pE202, DOI 10.1002/ccd.26379
  23. Jafri M, 2008, ANTI-CANCER DRUG, V19, P927, DOI 10.1097/CAD.0b013e3283100e9c
  24. Kogame N, 2019, EUROINTERVENTION, V15, pE547, DOI 10.4244/EIJ-D-19-00131
  25. Landes U, 2017, CORONARY ARTERY DIS, V28, P5, DOI 10.1097/MCA.0000000000000429
  26. Lanza GA, 2011, CIRCULATION, V124, P1774, DOI 10.1161/CIRCULATIONAHA.111.037283
  27. Lee AYY, 2003, CIRCULATION, V107, pI17, DOI 10.1161/01.CIR.0000078466.72504.AC
  28. Lee YC, 2015, BREAST CANCER RES TR, V152, P429, DOI 10.1007/s10549-015-3481-5
  29. Lenneman CG, 2016, CIRC RES, V118, P1008, DOI 10.1161/CIRCRESAHA.115.303633
  30. Levine GN, 2016, CIRCULATION, V134, pE123, DOI 10.1161/CIR.0000000000000404
  31. Long MY, 2020, BMC PHARMACOL TOXICO, V21, DOI 10.1186/s40360-020-00409-2
  32. Maynard C, 2006, ARCH INTERN MED, V166, P1410, DOI 10.1001/archinte.166.13.1410
  33. Mehran R, 2019, NEW ENGL J MED, V381, P2032, DOI 10.1056/NEJMoa1908419
  34. Mercurio V, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9070641
  35. Moore RA, 2011, J CLIN ONCOL, V29, P3466, DOI 10.1200/JCO.2011.35.5669
  36. Nakatsuma K, 2018, EUR HEART J-QUAL CAR, V4, P200, DOI 10.1093/ehjqcco/qcy014
  37. Narayan V, 2018, ANNU REV MED, V69, P97, DOI 10.1146/annurev-med-041316-090622
  38. Navi BB, 2017, J AM COLL CARDIOL, V70, P927, DOI 10.1016/j.jacc.2017.06.047
  39. Neumann FJ, 2019, EUROINTERVENTION, V14, P1435, DOI [10.1093/ejcts/ezy289, 10.1093/eurheartj/ehy394]
  40. Ozaki Takefumi, 2010, J Cardiol Cases, V1, pe52, DOI 10.1016/j.jccase.2009.07.005
  41. Park JY, 2019, INT J CARDIOL, V275, P6, DOI 10.1016/j.ijcard.2018.10.008
  42. Ranpura V, 2010, ACTA ONCOL, V49, P287, DOI 10.3109/02841860903524396
  43. Rhee TM, 2018, JACC-CARDIOVASC INTE, V11, P2453, DOI 10.1016/j.jcin.2018.09.020
  44. ROWINSKY EK, 1991, J CLIN ONCOL, V9, P1704, DOI 10.1200/JCO.1991.9.9.1704
  45. Ryan TD, 2019, CARDIOL CLIN, V37, P533, DOI 10.1016/j.ccl.2019.07.002
  46. Sayin BY, 2018, AM J CARDIOVASC DRUG, V18, P361, DOI 10.1007/s40256-018-0286-z
  47. Scappaticci FA, 2007, JNCI-J NATL CANCER I, V99, P1232, DOI 10.1093/jnci/djm086
  48. Seleme VB, 2019, CIRCULATION, V140
  49. Senkus E, 2011, CANCER TREAT REV, V37, P300, DOI 10.1016/j.ctrv.2010.11.001
  50. Shah K, 2012, J CANCER RES THER, V8, P442, DOI 10.4103/0973-1482.103530
  51. Snider KL, 2009, TARGET ONCOL, V4, P67, DOI 10.1007/s11523-009-0106-0
  52. Takamatsu H, 2010, INT J HEMATOL, V91, P903, DOI 10.1007/s12185-010-0586-9
  53. Teragawa H, 1996, JPN HEART J, V37, P905
  54. Tuzovic Mirela, 2018, Curr Treat Options Cardiovasc Med, V20, P40, DOI 10.1007/s11936-018-0635-x
  55. Ueki Y, 2019, JACC-CARDIOONCOL, V1, P145, DOI 10.1016/j.jaccao.2019.11.001
  56. Urban P, 2019, CIRCULATION, V140, P240, DOI 10.1161/CIRCULATIONAHA.119.040167
  57. Valgimigli M, 2018, EUR HEART J, V39, P213, DOI 10.1093/eurheartj/ehx419
  58. van Nimwegen FA, 2016, J CLIN ONCOL, V34, P235, DOI 10.1200/JCO.2015.63.4444
  59. van Nimwegen FA, 2015, JAMA INTERN MED, V175, P1007, DOI 10.1001/jamainternmed.2015.1180
  60. Vranckx P, 2018, LANCET, V392, P940, DOI 10.1016/S0140-6736(18)31858-0
  61. Yang Q, 2020, ARQ BRAS CARDIOL, V114, P1004, DOI 10.36660/abc.20190201
  62. Young A, 2012, NAT REV CLIN ONCOL, V9, P437, DOI 10.1038/nrclinonc.2012.106
  63. Yusuf SW, 2012, CLIN CARDIOL, V35, P443, DOI 10.1002/clc.22007
  64. Zamorano JL, 2016, EUR HEART J, V37, P2768, DOI 10.1093/eurheartj/ehw211
  65. Zwicker JI, 2016, J THROMB HAEMOST, V14, P1736, DOI 10.1111/jth.13387

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCP
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/08
Artigos e Materiais de Revistas Científicas - ODS/03